1. Home
  2. CNL vs RIGL Comparison

CNL vs RIGL Comparison

Compare CNL & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNL
  • RIGL
  • Stock Information
  • Founded
  • CNL 2018
  • RIGL 1996
  • Country
  • CNL Canada
  • RIGL United States
  • Employees
  • CNL N/A
  • RIGL N/A
  • Industry
  • CNL
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNL
  • RIGL Health Care
  • Exchange
  • CNL NYSE
  • RIGL Nasdaq
  • Market Cap
  • CNL 460.2M
  • RIGL 486.4M
  • IPO Year
  • CNL N/A
  • RIGL 2000
  • Fundamental
  • Price
  • CNL $6.02
  • RIGL $20.09
  • Analyst Decision
  • CNL Strong Buy
  • RIGL Buy
  • Analyst Count
  • CNL 1
  • RIGL 5
  • Target Price
  • CNL $7.00
  • RIGL $34.80
  • AVG Volume (30 Days)
  • CNL 18.2K
  • RIGL 226.6K
  • Earning Date
  • CNL 01-01-0001
  • RIGL 03-04-2025
  • Dividend Yield
  • CNL N/A
  • RIGL N/A
  • EPS Growth
  • CNL N/A
  • RIGL N/A
  • EPS
  • CNL N/A
  • RIGL 0.22
  • Revenue
  • CNL N/A
  • RIGL $157,374,000.00
  • Revenue This Year
  • CNL N/A
  • RIGL $51.34
  • Revenue Next Year
  • CNL $100.00
  • RIGL $15.75
  • P/E Ratio
  • CNL N/A
  • RIGL $90.73
  • Revenue Growth
  • CNL N/A
  • RIGL 21.65
  • 52 Week Low
  • CNL $2.43
  • RIGL $7.48
  • 52 Week High
  • CNL $6.50
  • RIGL $29.82
  • Technical
  • Relative Strength Index (RSI)
  • CNL N/A
  • RIGL 45.75
  • Support Level
  • CNL N/A
  • RIGL $20.00
  • Resistance Level
  • CNL N/A
  • RIGL $21.93
  • Average True Range (ATR)
  • CNL 0.00
  • RIGL 1.30
  • MACD
  • CNL 0.00
  • RIGL -0.27
  • Stochastic Oscillator
  • CNL 0.00
  • RIGL 2.01

About CNL COLLECTIVE MINING LTD

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has 100% interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: